GLP1-GLP1Detailed Description

GLP1-GLP1 Detailed Description

GLP1 Science is the first DAO to promote GLP-1 research to promote obesity, diabetes and metabolic health. GLP-1 agonists (e.g. Ozempic, Mounjaro) are the fastest growing drug category in the world, with sales expected to reach USD 129B+ by 2029. However, challenges remain, such as increasing weight loss by more than 20% and solving muscle loss problems